First experiences with 177Lu-PSMA-617 therapy for recurrent or metastatic salivary gland cancer

被引：0
|
作者：
Thomas J. W. Klein Nulent
Robert J. J. van Es
Stefan M. Willems
Arthur. J. A. T. Braat
Lot A. Devriese
Remco de Bree
Bart de Keizer
机构：
[1] University Medical Center Utrecht,Department of Head and Neck Surgical Oncology
[2] University Medical Center Utrecht,Department of Oral and Maxillofacial Surgery
[3] University Medical Center Utrecht,Department of Pathology
[4] University Medical Center Groningen,Department of Pathology and Medical Biology
[5] University Medical Center Utrecht,Department of Radiology and Nuclear Medicine
[6] University Medical Center Utrecht,Department of Medical Oncology
来源：
EJNMMI Research | / 11卷
关键词：
Lutetium; Positron-emission tomography; Radionuclide; Adenoid cystic carcinoma; Salivary gland cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Re-Rechallenge 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer
    Aggarwal, Piyush
    Gunasekaran, Vinisha
    Sood, Ashwani
    Kumar, Narendra
    Rathore, Yogesh
    Kumar, Rajender
    Mittal, Bhagwant Rai
    CLINICAL NUCLEAR MEDICINE, 2025, 50 (03) : 231 - 233
  • [32] Radioligand therapy with 177Lu-PSMA-617 of metastatic prostate cancer has already been arrived in clinical use
    Ahmadzadehfar, Hojjat
    Essler, Markus
    Schaefers, Michael
    Rahbar, Kambiz
    NUCLEAR MEDICINE AND BIOLOGY, 2016, 43 (12) : 835 - 835
  • [33] Circulating tumor cell molecular signatures of response to 177Lu-PSMA-617 therapy in metastatic prostate cancer patients
    Miyazawa, Yoshiyuki
    Konik, Arda
    Otani, Keisuke
    Pittie, Rea
    Rodden, Daniel
    Kelly, Justin
    Chung, Ella
    Ohtani, Yukako
    Badusi, Priscilla
    Pompa, Isabella
    Wan, Joshua
    Gao, Xin
    Kako, Bashar
    O'Shea, Aileen
    Heidari, Pedram
    Juric, Dejan
    Chevalier, Nicholas
    Miller, Miles
    Miyamoto, David
    Ng, Thomas
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [34] Radioligand Therapy With 177Lu-PSMA-617 as A Novel Therapeutic Option in Patients With Metastatic Castration Resistant Prostate Cancer
    Rahbar, Kambiz
    Bode, Axel
    Weckesser, Matthias
    Avramovic, Nemanja
    Claesener, Michael
    Stegger, Lars
    Boegemann, Martin
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (07) : 522 - 528
  • [35] Efficacy and Safety of 177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Patients
    Yadav, Madhav Prasad
    Ballal, Sanjana
    Bal, Chandrashekhar
    Sahoo, Ranjit Kumar
    Damle, Nishikant Avinash
    Tripathi, Madhavi
    Seth, Amlesh
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (01) : 19 - 31
  • [36] Hematologic safety of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer
    Daniel Groener
    Cam Tu Nguyen
    Justus Baumgarten
    Benjamin Bockisch
    Karen Davis
    Christian Happel
    Nicolai Mader
    Christina Nguyen Ngoc
    Jennifer Wichert
    Severine Banek
    Philipp Mandel
    Felix K. H. Chun
    Nikolaos Tselis
    Frank Grünwald
    Amir Sabet
    EJNMMI Research, 11
  • [37] Hematologic safety of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer
    Groener, Daniel
    Cam Tu Nguyen
    Baumgarten, Justus
    Bockisch, Benjamin
    Davis, Karen
    Happel, Christian
    Mader, Nicolai
    Ngoc, Christina Nguyen
    Wichert, Jennifer
    Banek, Severine
    Mandel, Philipp
    Chun, Felix K. H.
    Tselis, Nikolaos
    Gruenwald, Frank
    Sabet, Amir
    EJNMMI RESEARCH, 2021, 11 (01)
  • [38] Predictors of better response to radioligand therapy of metastatic castrate-resistant prostate cancer with 177Lu-PSMA-617
    Ferdinandus, J.
    Eppard, E.
    Kuerpig, S.
    Gaertner, F.
    Fimmers, R.
    Yordanova, A.
    Hauser, S.
    Essler, M.
    Feldmann, G.
    Ahmadzadehfar, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S212 - S213
  • [39] Feasibility of 177Lu-PSMA-617 radioligand therapy in a patient with recurrent high-grade glioma
    Holzgreve, A.
    Delker, A.
    Wenter, V.
    Zacherl, M. J.
    Thon, N.
    Harter, P.
    Brendel, M.
    Unterrainer, L. M.
    Niyazi, M.
    Bartenstein, P.
    von Baumgarten, L.
    Albert, N. L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S217 - S217
  • [40] Antitumor activity of repeated 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration resistant prostate cancer
    Rahbar, Kambiz
    Braeuer, Axel
    Yordanova, Anna
    Boegemann, Martin
    Hauser, Stefan
    Eveslage, Maria
    Essler, Markus
    Schafers, Michael
    Ahmadzadehfar, Hojjat
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
12345